Axogen, Inc. - 8-K Filing

Axogen completes acquisition of BioCircuit Technologies and adds NerveTape™ for sutureless nerve repair (Items: 7.01 Regulation FD DisclosureOn October 1, 2026, Axogen, Inc, 9.01 Financial Statements and Exhibits(d) ExhibitsExhibit No)

SEC EDGAR ·

Tickers: $AXGN

Read the full article at SEC EDGAR

More Regulatory news